
|Articles|February 15, 2004
Corneal collagen cross-linking halts keratoconus progression
Anaheim, CA-Cross-linking of corneal collagen by topical treatment with riboflavin and ultraviolet (UV) light exposure shows promise as a safe, effective, simple, and inexpensive nonsurgical treatment for keratoconus, said Theo Seiler, MD, PhD, at the annual meeting of the American Academy of Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
2
Metformin use associated with reduced incidence of intermediate AMD
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























